Fabrication of 3-D highly porous, bioactive, and mechanically competent scaffolds represents a significant challenge of bone tissue engineering. In this work, Bioglass®-derived glass-ceramic scaffolds actually fulfilling this complex set of requirements were successfully produced through the sponge replication method. Scaffold processing parameters and sintering treatment were carefully designed in order to obtain final porous bodies with pore content (porosity above 70 %vol), trabecular architecture and mechanical properties (compressive strength up to 3 MPa) analogous to those of the cancellous bone. Influence of the Bioglass® particles size on the structural and mechanical features of the sintered scaffolds was considered and discussed. Relationship between porosity and mechanical strength was investigated and modeled. Three-dimensional architecture, porosity, mechanical strength and in vitro bioactivity of the optimized Bioglass®-derived scaffolds were also compared to those of CEL2-based glass-ceramic scaffolds (CEL2 is an experimental bioactive glass originally developed by the authors at Politecnico di Torino) fabricated by the same processing technique, in an attempt at understanding the role of different bioactive glass composition on the major features of scaffolds prepared by the same method.
HenchLL. The Story of Bioglass®. J Mater Sci Mater Med2006; 17: 967–978.
9.
JonesJRGentlemanEPolakJ. Bioactive glass scaffolds for bone regeneration. Elements2007; 3: 393–399.
10.
ChevalierJGremillardL. Ceramics for medical applications: a picture for the next 20 years. J Eur Ceram Soc2009; 29: 1245–1255.
11.
HenchLLSplinterRJAllenWCGreenleeTK. Bonding Mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res1972; 2: 117–141.
12.
Baino F and Vitale-BrovaroneC. Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future. J Biomed Mater Res A2011; 97: 514–535.
13.
XynosIDEdgarAJButteryLDHenchLLPolakJM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res2001; 55: 151–157.
HoppeAGuldalNSBoccacciniAR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials2011; 32: 2757–2774.
16.
ChenQZThompsonIDBoccacciniAR. 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials2006; 27: 2414–2425.
WuSCHsuHCHsiaoSHHoWF. Preparation of porous 45S5 bioglass®-derived glass-ceramic scaffolds by using rice husk as a porogen additive. J Mater Sci Mater Med2009; 20: 1229–1236.
19.
KarageorgiouVKaplanD. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials2005; 26: 5474–5491.
20.
BellucciDCannilloVSolaA. Shell scaffolds: a new approach towards high strength bioceramic scaffolds for bone regeneration. Mater Lett2010; 64: 203–206.
21.
Vitale-BrovaroneCBainoFVernéE. High strength bioactive glass-ceramic scaffolds for bone regeneration. J Mater Sci Mater Med2009; 20: 643–653.
22.
Vitale-BrovaroneCVernéERobiglioLMartinassoGCanutoRAMuzioG. Biocompatible glass-ceramic materials for bone substitution. J Mater Sci Mater Med2008; 19: 471–478.
23.
Vitale-BrovaroneCVernéERobiglioLAppendinoPBassiFMartinassoGMuzioGCanutoR. Development of glass-ceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater2007; 3: 199–208.
24.
KokuboTTakadamaH. How useful is SBF in predicting in vivo bone bioactivity?Biomaterials2006; 27: 2907–2915.
25.
ErolMKucukbayrakSErsoy-MericboyuA. Influence of particle size on the crystallization kinetics of glasses produced from waste materials. J Non-Cryst Solids2011; 357: 211–219.
26.
BretcanuOChatzistavrouXParaskevpoulosKConradtRThompsonI. and Boccaccini, A.R. Sintering and crystallization of 45S5 bioglass® powder. J Eur Ceram Soc2009; 29: 3299–3306.
27.
HuangRPanJBoccacciniARChenQZ. A two-scale model for simultaneous sintering and crystallization of glass–ceramic scaffolds for tissue engineering. Acta Biomater2008; 4: 1095–1103.
28.
HrubyA. Evaluation of glass-forming tendency by means of DTA. Czech J Phys1972; 22: 1187–1193.
29.
PandaPCRajR. Sintering and crystallization of glass at constant heating rate. J Am Ceram Soc1989; 69: 1564–1566.
LaraCPascualMJDuranA. Glass-forming ability, sinterability and thermal properties in the system RO-BaO-SiO2 (R = Mg, Zn). J Non-Cryst Solids2004; 348: 149–155.
32.
LinCCHuangLCShenP. Na2CaSi2O6-P2O5 Based bioactive glasses. Part I: elasticity and structure. J Non-Cryst Solids2005; 351: 3195–3203.
33.
LefebvreLChevalierJGremillardLZenatiRTholletGBernache-AssolantD. Structural transformation of bioactive glass 45S5 with thermal treatments. Acta Mater2007; 55: 3305–3313.
BellucciDCannilloVSolaAChielliniFGazzarriMMigoneC. Macroporous Bioglass®-derived scaffolds for bone tissue regeneration. Ceram Int2011; 37: 1575–1585.
36.
Vitale-BrovaroneCBainoFBretcanuOVernéE. Foam-like scaffolds for bone tissue engineering based on a novel couple of silicate-phosphate specular glasses: synthesis and properties. J Mater Sci Mater Med2009; 20: 2197–2205.
37.
Vitale-BrovaroneCBainoFVernéE. Feasibility and tailoring of bioactive glass-ceramic scaffolds with gradient of porosity for bone grafting. J Biomater Appl2010; 24: 693–712.
38.
Vitale-BrovaroneCMiolaMBalagnaCVernéE. 3D Glass-ceramic scaffolds with antibacterial properties for bone grafting. Chem Eng J2008; 137: 129–136.
39.
BalagnaCVitale-BrovaroneCMiolaMCanutoRASaracinoSMuzioG. Biocompatibility and antibacterial effect of silver doped 3D-glass-ceramic scaffolds for bone grafting. J Biomater Appl2011; 25: 595–617.
40.
FuQRahamanMNSonny BalBBrownRFDayDE. Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater2008; 4: 1854–1864.
41.
FuHFuQZhouNHuangWRahamanMNWangD. and Liu, X. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method. Mater Sci Eng C2009; 29: 2275–2281.
42.
LiuXHuangWFuHYaoAWangDPanHLuWW. Bioactive borosilicate glass scaffolds: improvement on the strength of glass-based scaffolds for tissue engineering. J Mater Sci Mater Med2009; 20: 365–372.
43.
Vitale-BrovaroneCCiapettiGLeonardiEBaldiniNBretcanuOVernéE. Resorbable glass-ceramic phosphate-based scaffolds for bone tissue engineering: synthesis, properties and in vitro effects on human marrow stromal cells. J Biomater Appl2011; 26: 465–489.
44.
JonesJREhrenfriedLMHenchLL. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials2006; 27: 964–973.
45.
GerhardtLCBoccacciniAR. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials2010; 3: 3867–3910.
46.
FritschADormieuxLHellmichCSanahujaJ. Mechanical behavior of hydroxyapatite biomaterials: an experimentally validated micromechanical model for elasticity and strength. J Biomed Mater Res A2007; 88: 149–161.
47.
MalasomaAFritschAKohlhauserCBrynkTVitale-BrovaroneCPakielaZ. Micromechanics of bioresorbable porous CEL2 glass ceramic scaffolds for bone tissue engineering. Adv Appl Ceram2008; 107: 277–286.
48.
BainoFVernéEVitale-BrovaroneC. 3-D high strength glass-ceramic scaffolds containing fluoroapatite for load-bearing bone portions replacement. Mater Sci Eng C2009; 29: 2055–2062.
49.
ClupperDCMecholskyJJJr.LaTorreGP. and Greenspan, D.C. Bioactivity of tape cast and sintered glass-ceramic in simulated body fluid. Biomaterials2002; 23: 2599–2606.
50.
LiPZhangFKokuboT. The effect of residual glassy phase in a bioactive glass-ceramic on the formation of its surface apatite layer in vitro. J Mater Sci Mater Med1992; 3: 452–456.
51.
PeitlFOLaTorreGPHenchLL. Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res1996; 30: 509–514.
52.
RenghiniCKomlevVFioriFVernéEBainoF. and Vitale-Brovarone, C. Micro-CT studies on 3-D bioactive glass-ceramic scaffolds for bone regeneration. Acta Biomater2009; 5: 1328–1337.
